Literature DB >> 573210

Effects of captivity on glucose tolerance in dogs.

F Lechin, E Coll-Garcia, B van der Dijs, A Bentolila, F Peña, C Rivas.   

Abstract

Captivity decreased tolerance to glucose and increased blood serotonin levels in 6 normal dogs investigated. Return to freedom brought normalization in the glucose tolerance test and reverted blood serotonin to control levels.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 573210     DOI： 10.1007/bf01955123

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  20 in total

1.  Effects of chronic exposure to stressors on avoidance-escape behavior and on brain norepinephrine.

Authors:  J M Weiss; H I Glazer; L A Pohorecky; J Brick; N E Miller
Journal:  Psychosom Med       Date:  1975 Nov-Dec       Impact factor: 4.312

2.  ESTIMATION OF 5-HYDROXYTRYPTAMINE IN HUMAN BLOOD.

Authors:  G W ASHCROFT; T B CRAWFORD; J K BINNS; E J MACDOUGALL
Journal:  Clin Chim Acta       Date:  1964-04       Impact factor: 3.786

3.  A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.

Authors:  P Jenner; P N Elliott; A Clow; C Reavill; C D Marsden
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

4.  Evidence for dopamine receptors in the human brain mediating sedation and sleep.

Authors:  G U Corsini; M Del Zompo; S Manconi; M P Piccardi; P L Onali; A Mangoni
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

5.  The dopaminergic and noradrenergic blockades: a new treatment for headache.

Authors:  F Lechin; B van der Dijs; E Lechin; F Peña; A Bentolila
Journal:  Headache       Date:  1978-05       Impact factor: 5.887

6.  Serotonin inhibition of in vitro insulin release from golden hamster pancreas.

Authors:  J M Feldman; H E Lebovitz
Journal:  Endocrinology       Date:  1970-01       Impact factor: 4.736

7.  Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover.

Authors:  A M Thierry; F Javoy; J Glowinski; S S Kety
Journal:  J Pharmacol Exp Ther       Date:  1968-09       Impact factor: 4.030

8.  Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of metabolic alpha-adrenergic pathways.

Authors:  S A Metz; J B Halter; R P Robertson
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

9.  The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.

Authors:  F Lechin; E Coll-García; B van der Dijs; A Bentolila; F Peña; C Rivas
Journal:  Experientia       Date:  1979-07-15

10.  Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.

Authors:  J Del Rio; J Madroñal
Journal:  Eur J Pharmacol       Date:  1976-10       Impact factor: 4.432
View more
  3 in total

1.  The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.

Authors:  F Lechin; E Coll-García; B van der Dijs; A Bentolila; F Peña; C Rivas
Journal:  Experientia       Date:  1979-07-15

Review 2.  Central nervous system plus autonomic nervous system disorders responsible for gastrointestinal and pancreatobiliary diseases.

Authors:  Fuad Lechin; Bertha van der Dijs
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

3.  Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms.

Authors:  Fuad Lechin; Bertha van der Dijs; Betty Pardey-Maldonado; Jairo E Rivera; Marcel E Lechin; Scarlet Baez
Journal:  Diabetes Metab Syndr Obes       Date:  2009-12-02       Impact factor: 3.168
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.